MENU
+Compare
TNXP
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$16.10
Change
+$0.46 (+2.94%)
Capitalization
189.25M

TNXP Tonix Pharmaceuticals Holding Corp Forecast, Technical & Fundamental Analysis

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

TNXP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TNXP with price predictions
Nov 21, 2025

TNXP's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for TNXP turned positive on October 20, 2025. Looking at past instances where TNXP's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TNXP's RSI Indicator exited the oversold zone, of 54 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TNXP advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TNXP as a result. In of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TNXP entered a downward trend on November 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.819) is normal, around the industry mean (27.205). P/E Ratio (0.058) is within average values for comparable stocks, (51.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (9.542) is also within normal values, averaging (328.409).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TNXP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNXP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TNXP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TNXP is expected to report earnings to rise 16.43% to -417 cents per share on March 16

Tonix Pharmaceuticals Holding Corp TNXP Stock Earnings Reports
Q4'25
Est.
$-4.18
Q3'25
Est.
$-3.59
Q2'25
Beat
by $2.97
Q1'25
Beat
by $22.84
Q4'24
Missed
by $5.86
The last earnings report on November 10 showed earnings per share of -358 cents, meeting the estimate of -358 cents. With 661.86K shares outstanding, the current market capitalization sits at 189.25M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and manufacturing pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
26 Main Street
Phone
+1 862 799-8599
Employees
103
Web
https://www.tonixpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CJREF0.03N/A
+5.23%
Corus Entertainment, Inc.
AMSYF37.25N/A
N/A
ArcelorMittal
FUPPF48.00N/A
N/A
FUCHS SE
HLFFF6.11N/A
N/A
Hellofresh SE
KMNCF0.39N/A
N/A
Kingsmen Creatives Ltd.

TNXP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with ICU. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then ICU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
+2.75%
ICU - TNXP
77%
Closely correlated
+1.77%
NEVPF - TNXP
41%
Loosely correlated
N/A
TOVX - TNXP
35%
Loosely correlated
+0.79%
CRVS - TNXP
32%
Poorly correlated
+0.71%
IPHA - TNXP
30%
Poorly correlated
+1.10%
More

Groups containing TNXP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
+2.75%
TNXP
(2 stocks)
100%
Closely correlated
+2.26%